CA Stock MarketDetailed Quotes

AGN Algernon Pharmaceuticals Inc

Watchlist
  • 0.085
  • +0.010+13.33%
15min DelayMarket Closed Mar 4 09:30 ET
2.32MMarket Cap-8.50P/E (TTM)

Algernon Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.95%381.32K
-53.99%2.41M
-57.38%420.2K
-58.72%465.66K
-19.52%1M
-72.24%521.97K
-12.92%5.24M
-54.80%985.85K
40.80%1.13M
-32.06%1.25M
Selling and administrative expenses
-1.66%348.52K
-57.54%1.76M
-51.70%385.17K
-46.64%356.12K
-42.54%665.2K
-76.75%354.4K
11.28%4.15M
-41.64%797.49K
-6.51%667.45K
8.02%1.16M
-Selling and marketing expense
14.10%119.65K
-74.51%321.35K
-32.94%145.99K
-80.74%29.95K
-86.89%40.55K
-81.87%104.86K
72.75%1.26M
-35.93%217.7K
26.41%155.55K
148.79%309.16K
-General and administrative expense
-8.28%228.88K
-50.12%1.44M
-58.75%239.18K
-36.28%326.17K
-26.39%624.65K
-73.62%249.54K
-3.69%2.89M
-43.53%579.79K
-13.37%511.91K
-10.44%848.58K
Research and development costs
-80.43%32.8K
-40.54%651.16K
-81.40%35.03K
-76.22%109.53K
276.45%339.01K
-52.95%167.58K
-52.25%1.1M
-76.88%188.36K
427.98%460.58K
-88.22%90.06K
Operating profit
26.95%-381.32K
53.99%-2.41M
57.38%-420.2K
58.72%-465.66K
19.52%-1M
72.24%-521.97K
12.92%-5.24M
54.80%-985.85K
-40.80%-1.13M
32.06%-1.25M
Net non-operating interest income (expenses)
-38.10%260
-34.76%1.37K
-65.83%260
-48.23%380
0.00%308
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
Non-operating interest income
-38.10%260
-34.76%1.37K
-65.83%260
-48.23%380
0.00%308
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
Other net income (expenses)
223.77%1.91M
-1.49K
1.91M
-4,125.19%-1.54M
Special income (charges)
----
115.93%245.46K
--0
--245.46K
----
----
-4,125.19%-1.54M
---1.54M
--0
----
-Less:Impairment of capital assets
----
--0
----
----
----
----
4,125.19%1.54M
----
----
----
-Less:Other special charges
----
---245.46K
--0
---245.46K
----
----
----
----
----
----
Other non-operating income (expenses)
----
--1.66M
---1.49K
--1.66M
----
----
----
----
----
----
Income before tax
26.94%-381.06K
92.58%-502.98K
83.32%-421.43K
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
Income tax
Earnings from equity interest net of tax
Net income
26.94%-381.06K
92.58%-502.98K
83.32%-421.43K
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
Net income continuous operations
26.94%-381.06K
92.58%-502.98K
83.32%-421.43K
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
Noncontrolling interests
Net income attributable to the company
26.94%-381.06K
92.58%-502.98K
83.32%-421.43K
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
26.94%-381.06K
92.58%-502.98K
83.32%-421.43K
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
Diluted earnings per share
66.67%-0.01
93.33%-0.03
90.36%-0.0154
170.00%0.07
61.54%-0.05
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
Basic earnings per share
66.67%-0.01
93.33%-0.03
90.36%-0.0154
160.00%0.06
61.54%-0.05
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.95%381.32K-53.99%2.41M-57.38%420.2K-58.72%465.66K-19.52%1M-72.24%521.97K-12.92%5.24M-54.80%985.85K40.80%1.13M-32.06%1.25M
Selling and administrative expenses -1.66%348.52K-57.54%1.76M-51.70%385.17K-46.64%356.12K-42.54%665.2K-76.75%354.4K11.28%4.15M-41.64%797.49K-6.51%667.45K8.02%1.16M
-Selling and marketing expense 14.10%119.65K-74.51%321.35K-32.94%145.99K-80.74%29.95K-86.89%40.55K-81.87%104.86K72.75%1.26M-35.93%217.7K26.41%155.55K148.79%309.16K
-General and administrative expense -8.28%228.88K-50.12%1.44M-58.75%239.18K-36.28%326.17K-26.39%624.65K-73.62%249.54K-3.69%2.89M-43.53%579.79K-13.37%511.91K-10.44%848.58K
Research and development costs -80.43%32.8K-40.54%651.16K-81.40%35.03K-76.22%109.53K276.45%339.01K-52.95%167.58K-52.25%1.1M-76.88%188.36K427.98%460.58K-88.22%90.06K
Operating profit 26.95%-381.32K53.99%-2.41M57.38%-420.2K58.72%-465.66K19.52%-1M72.24%-521.97K12.92%-5.24M54.80%-985.85K-40.80%-1.13M32.06%-1.25M
Net non-operating interest income (expenses) -38.10%260-34.76%1.37K-65.83%260-48.23%3800.00%30842.86%4200.91%2.1K64.01%76133.45%734-48.58%308
Non-operating interest income -38.10%260-34.76%1.37K-65.83%260-48.23%3800.00%30842.86%4200.91%2.1K64.01%76133.45%734-48.58%308
Other net income (expenses) 223.77%1.91M-1.49K1.91M-4,125.19%-1.54M
Special income (charges) ----115.93%245.46K--0--245.46K---------4,125.19%-1.54M---1.54M--0----
-Less:Impairment of capital assets ------0----------------4,125.19%1.54M------------
-Less:Other special charges -------245.46K--0---245.46K------------------------
Other non-operating income (expenses) ------1.66M---1.49K--1.66M------------------------
Income before tax 26.94%-381.06K92.58%-502.98K83.32%-421.43K228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M
Income tax
Earnings from equity interest net of tax
Net income 26.94%-381.06K92.58%-502.98K83.32%-421.43K228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M
Net income continuous operations 26.94%-381.06K92.58%-502.98K83.32%-421.43K228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M
Noncontrolling interests
Net income attributable to the company 26.94%-381.06K92.58%-502.98K83.32%-421.43K228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 26.94%-381.06K92.58%-502.98K83.32%-421.43K228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M
Diluted earnings per share 66.67%-0.0193.33%-0.0390.36%-0.0154170.00%0.0761.54%-0.0585.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13
Basic earnings per share 66.67%-0.0193.33%-0.0390.36%-0.0154160.00%0.0661.54%-0.0585.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.